What Justice Ginsburg’s Death Means For Pharma

A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.

US Supreme Court building at dusk, Washington

The death of US Supreme Court Justice Ruth Bader Ginsburg has prompted an outpouring of grief, but also set off political machinations that could have have long-term implications for the pharmaceutical industry.

A pioneering attorney who was the second women on the Supreme Court, Ginsburg became a cultural icon for progressives due...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet